AI News, PenNews
Baidu CEO gets water poured on his head at company AI event
(CNN) - One of China's top tech billionaires faced an unusual interruption to his speech at a company event on Wednesday, when a man walked on stage and drenched him with water.
Robin Li, the co-founder and CEO of Chinese tech company Baidu, was speaking about self-driving and connected cars when a young man dressed in a black shirt came on stage and emptied a bottle of water over Li's head.
Although the company remains China's dominant search engine, accounting for some 70% of the market share, its performance has fallen behind major rivals such as Tencent and Alibaba in recent months.
PenNews | PenRad
The method uses a language-modeling approaches trained on data from multiple hospitals and ambulatory sites and can serve as an important basis to continually improve specificity and user preferences in automatically correlating radiology and pathology reports, according to the study’s only author, Ross Filice, MD, with MedStar Georgetown University Hospital, Washington, D.C.”
(#162) Same-day biopsy program can address disparities among breast cancer patients (Radiology Business June 3, 2019) “Implementing a same-day biopsy program can help providers address ongoing disparities in patient care, according to a new study published in the Journal of the American College of Radiology.
(#161) AI can dramatically reduce mammography reads for radiologists (Health Imaging May 31, 2019) “Machine learning can reduce a radiologists workload by lowering the number of screening mammograms they’re required to read while preserving accuracy, according to results of a feasibility study published in the Journal of the American College of Radiology.
(#160) ASCO: In early study results, Grail’s blood test identifies 12 cancers before they spread (Fierce Biotech May 31, 2019) “New, early data from Grail showed its liquid biopsy test was not only able to detect the presence of 12 different kinds of early-stage cancer but could also identify the disease’s location within the body before it spreads using signatures found in the bloodstream.
(#159) Deep-learning tool smartly steers patients toward—or away from—breast biopsy (AI in Healthcare May 30, 2019) “Researchers in Texas and Taiwan have collaborated to develop a deep-learning tool that can precisely asses the risk of breast cancer—and with it the need for biopsy—in patients with lesions of questionable concern found in mammograms.
(#157) Google’s cancer-spotting AI outperforms radiologists in reading lung CT scans (Fierce BioTech May 22, 2019) “Google’s artificial intelligence development has reached a milestone in lung cancer imaging and prediction, with a CT scan model being able to diagnose cases as well as or better than a group of six radiologists.
(#156) How radiologists can use mammography to improve lung cancer screening utilization (Radiology Business May 17, 2019) “Many women who undergo screening mammography are also eligible for lung cancer screening (LCS), according to a new study published by the Journal of the American College of Radiology.
(#155) JAMA: 3 concerns surrounding mandatory breast density notification (Health Imaging May 15, 2019) “On February 15 of this year, Congress passed national breast density legislation, which mandates all mammography reports and summaries notify women of their breast density.
(#154) Short-interval follow-up MRI helps ID early stage breast cancer (Health Imaging May 8, 2019) “Short-interval follow-up MRI can identify early stage breast cancer and reduce unnecessary biopsies, reported authors of a study to be presented at the American Roentgen Ray Society Annual Meeting in Honolulu.
Limiting surprise medical bills “Issues surrounding beneficiaries being burdened with high out-of-pocket costs and inadequate provider networks present real issues for patients in need of life saving diagnostic imaging services,” according to an ACR position statement.
(#151) MGH, MIT researchers create AI tool that predicts risk of breast cancer (Health Data Management May 9, 2019) “A deep learning model is able to accurately assess breast tissue density—an independent risk factor for breast cancer—in mammograms.
“We developed a deep learning model that uses full-field mammograms and traditional risk factors, and found that our model was more accurate than the Tyrer-Cusick model (version 8), a current clinical standard,” conclude researchers in a study published earlier this week in the journal Radiology.”
(#150) All women 25 years old and older should undergo a breast cancer risk assessment (Radiology Business May 3, 2019) “All women 25 years old and older should undergo a breast cancer risk assessment, according to a new position statement published by the American Society of Breast Surgeons (ASBrS).
(#149) AI predicts breast cancer risk 5 years in advance (Health Imaging May 7, 2019) “A team of researchers from MIT and Massachusetts General Hospital (MGH) have created an AI model capable of predicting a patient’s breast cancer risk five years in advance.
(#147) How the screening method impacts survival outcomes for patients with DCIS (Radiology Business April 30, 2019) “Patients with screening-detected ductal carcinoma in situ (DCIS) who were screened with mammography and ultrasound (US) have similar disease-free survival (DFS) rates, according to a new study published in Radiology.
(#146) Radiotherapy shown beneficial in early stage breast cancer patients (Health Imaging April 30, 2019) “Radiotherapy combined with hormonal therapy after surgery significantly reduced the chance of recurrence in women with early hormone receptor-positive (HR+) breast cancer, according to results of a 10-year trial presented at the European Society for Radiotherapy and Oncology (ESTRO) 38 conference in Milan, Italy.
(#144) ACP shares new breast cancer screening guidelines, imaging societies push back (Radiology Business April 8, 2019) “The American College of Physicians (ACP) now recommends that average-risk women with no symptoms undergo breast cancer screening with mammography every other year, beginning at the age of 50.
(#143) Genetic testing for newly diagnosed breast cancer patients could save $50M (Radiology Business April 25, 2019) “In 2018, results from the TAILORx clinical trial revealed that genetic testing could help a majority of women with HR-positive, HER2-negative, axillary node-negative breast cancer bypass chemotherapy since it would not benefit them any more than hormone therapy alone.
(#141) 4 steps to implementing abbreviated breast MRI screening into practice (Radiology Business April 22, 2019) “The high sensitivity associated with breast MRI makes it an effective tool for detecting breast cancer, but the costs and long acquisition times have kept it from being embraced as a supplemental screening option.
(#140) Free online tool reads chest X-rays as well as physicians (AI in Healthcare April 1, 2019) “A free web tool known as “Chester the AI Radiology Assistant” can assess a person’s chest X-rays online within seconds, ensuring patients’ private medical data remains secure while predicting their likelihood of having 14 diseases.
Chester, though still rudimentary, can process a user’s upload and output diagnostic predictions for atelectasis, cardiomegaly, effusion, infiltration, masses, nodules, pneumonia, pneumothorax, consolidation, edema, emphysema, fibrosis, pleural thickening and hernias with 80 percent accuracy.
(#137) AI model predicts a patient’s breast cancer risk from single MR image (Radiology Business April 2, 2019) “Researchers have developed a deep learning (DL) model that assesses a woman’s five-year cancer risk with a single breast MR image, sharing their findings in the American Journal of Roentgenology.
(#136) Older women benefit from breast cancer screening with DBT (Radiology Business April 2, 2019) “Breast cancer screening with digital breast tomosynthesis (DBT) provides significant value to older women, according to a new study published in Radiology.
(#134) Breast density assessments vary depending on the screening technique (Radiology Business March 20, 2019) “Breast density assessments using digital breast tomosynthesis (DBT) and synthetic mammography (SM) vary significantly compared to those performed using standard digital mammography (DM), according to a new study published by Radiology.
(#133) FDA proposed rule ‘modernizes’ mammography screening, includes breast density reporting (Radiology Business March 27, 2019) “The FDA announced Wednesday, March 27, that it is taking action to “modernize” breast cancer screening in the United States by amending the Mammography Quality Standards Act of 1992 with a new proposed rule.
(#132) PET biomarkers may lead to individualized treatment for breast cancer (Applied Radiology March 22, 2019) “Positron emission tomography/computed tomography (PET/CT) scan biomarkers show potential for identifying breast cancer patients who may be able to forgo conventional chemotherapy before surgery.
(#131) Using water and gold, Australian researchers discover ‘universal cancer biomarker’ (Fierce Biotech December 5, 2018) “Australian researchers at the University of Queensland have discovered a unique DNA structure that appears to be shared by many cancers and could be used to develop a simple diagnostic test that could be performed in under 10 minutes with the naked eye.
(#129) An alternative approach for locating a mammographic lesion by ultrasound using a simple x,y coordinate system (PubMed.gov Nov/Dec, 2012) “Abstract: We present an accurate and reliable method for localizing a mammographic lesion by ultrasound using a simple coordinate system.
(#125) Increased background parenchymal enhancement level a key biomarker for breast cancer risk (Radiology Business March 20, 2019) “Increased background parenchymal enhancement (BPE) levels at breast MRI are associated with a greater risk of developing breast cancer within a year, according to new findings published in the American Journal of Roentgenology.
(#124) Breast density assessments vary depending on the screening technique (Radiology Business March 20, 2019) “Breast density assessments using digital breast tomosynthesis (DBT) and synthetic mammography (SM) vary significantly compared to those performed using standard digital mammography (DM), according to a new study published by Radiology.
(Radiology Business March 19, 2019) “In December 2018, the Canadian Task Force on Preventive Health Care issued updated breast cancer screening guidelines that recommended women aged 50 to 74 seek screening every two or three years and women aged 40 to 49 not undergo screening.
(#122) In another I-O first for Roche, Tecentriq nabs blockbuster small cell lung cancer nod (Fierce Pharma March 19, 2019) “Just a week after Roche’s Tecentriq became the first immuno-oncology agent the FDA approved for triple-negative breast cancer, the anti-PD-L1 drug has clinched another first-in-class approval—this time in lung cancer.
(#121) PET Scans Show Biomarkers Could Spare Some Breast Cancer Patients from Chemotherapy (Imaging Technology News March 18, 2019) “A new study of positron emission tomography (PET) scans has identified a biomarker that may accurately predict which patients with one type of HER2-positive breast cancer might best benefit from standalone HER2-targeted agents, without the need for standard chemotherapy.
(#111) Breast cancer prediction models more effective when they include family history data (Radiology Business February 26, 2019) “Breast cancer prediction models based on family history are more effective than those that do not focus on that information, according to a new study published in The Lancet Oncology.
(#107) IBM uses machine learning to detect early Alzheimer’s in blood samples (FierceBiotech March 11, 2019) “Long before memory loss occurs in patients with Alzheimer’s, the protein amyloid-beta—which has been implicated in the formation of brain tangles that characterize the disease—starts building up in the spinal fluid.
(#102) Deep neural network matches pathologists’ ability to identify lung cancer (AI in Healthcare March 8, 2019) “A deep neural network crafted by research specialists at Dartmouth’s Norris Cotton Cancer Center identified different types of lung adenocarcinoma as well as practicing pathologists in a recent study, according to work published March 4 in Scientific Reports.
(#101) How soon do women want to know their mammogram results? (Radiology Business February 20, 2019) “Most women are willing to wait for their screening mammogram results after the exam or receive their test results within 48 hours, according to new research published in the Journal of the American College of Radiology.
Shah, MD, a radiologist at the Virginia Commonwealth University Health System in Richmond, Virginia, also found from survey responses from 2,245 screening mammography patients 18 years and older that most (85.4 percent) preferred to receive abnormal screening mammogram results on a Friday—even if they couldn’t come in for a diagnostic workup until the following week. ”
Using recent advances in machine learning, the scientists, led by Hassanpour, developed a deep neural network to classify different types of lung adenocarcinoma on histopathology slides, and found that the model performed on par with three practicing pathologists.”
(#97) How did big policy changes impact cost sharing for screening mammography? (Radiology Business March 4, 2019) “Nearly all commercially insured women between the ages of 40 and 74 had access to screening mammography without cost sharing after the Affordable Care Act (ACA) was signed into law, according to new research published by the Journal of the American College of Radiology.
(#94) The future of voice recognition in healthcare — key thoughts from 8 CMIOs (Becker’s Healthcare November 27, 2018) “Eight chief medical information officers discuss voice recognition technology and how it could impact the healthcare industry, from clinical documentation to decision support tools.”
Although federal law now requires mammography facilities to include breast density information in reports for patients and their physicians, mammography screening recommendations are dependent on a women’s age and it can be difficult to determine which women with dense breasts will benefit the most from supplemental testing, according to Mango.”
(#91) New carotid imaging technique offers speedy, noninvasive CVD risk assessment (Cardiovascular Business February 12, 2019) “A new, noninvasive technique for imaging the carotid artery can offer insight into plaque characteristics in real time, leading one researcher to suggest the modality could become as popular as ultrasound.
(#89) 4 areas AI must excel in to improve women’s imaging (Health Imaging February 21, 2019) “For AI to become clinically feasible in women’s imaging, it must excel in the areas of performance, time, workflow and cost, according to an opinion piece published online Feb. 19 in the American Journal of Roentgenology.
(#88) Machine learning model may save women from unnecessary breast surgery (Health Imaging February 26, 2019) “Researchers have created a machine learning model that identified 98 percent of malignant atypical ductal hyperplasia (ADH) lesions prior to surgery, according to a single-center study published in JCO Clinical Cancer Informatics.
(#87) Can radiologists who interpret mammograms make the switch to DBT? (Health Imaging February 26, 2019) “Radiologists who interpret traditional two-dimensional (2D) mammograms required little time in transitioning to reading digital breast tomosynthesis (DBT) exams, or three-dimensional (3D) mammograms, and improved their accuracy in detecting cancer, according to research published online Feb. 26 in Radiology.
(#86) Breast cancer prediction models more effective when they include family history data (Radiology Business February 26, 2019) “Breast cancer prediction models based on family history are more effective than those that do not focus on that information, according to a new study published in The Lancet Oncology.
(#85) Ultrasound assesses bone health similarly to DXA, study finds (Health Imaging February 26, 2019) “Ultrasound scans of the calcaneus—or the heel bone—were equal to results gathered from dual-energy x-ray absorptiometry (DXA) for assessing bone health, according to new research published online in the March issue of The Journal of the American Osteopathic Association.
(#83) New carotid imaging technique offers speedy, noninvasive CVD risk assessment (Cardiovascular Business February 12, 2019) “A new, noninvasive technique for imaging the carotid artery can offer insight into plaque characteristics in real time, leading one researcher to suggest the modality could become as popular as ultrasound.
(#82) New guidelines recommend genetic testing for all breast cancer patients (Radiology Business February 15, 2019) “Genetic testing should be available for all breast cancer patients to determine hereditary risk in addition to standard imaging exams, according to new guidelines published Feb. 14 by The American Society of Breast Surgeons.
The new recommendations are based on an extensive review of supporting research, especially a study published in the Journal of Clinical Oncology in December which found that patients who met existing National Comprehensive Cancer Network (NCCN) clinical testing criteria had similar rates of genetic mutations in breast cancer genes as patients who did not meet the criteria.”
(#81) New federal law requires mammography providers to send breast density notifications (Radiology Business February 19, 2019) “When President Donald Trump signed a federal funding bill into law on Feb. 15, it included text that said that all mammography providers must include updated information about breast density in reports sent to both patients and their physicians.
National breast density inform legislation was enacted as part of the funding bill signed into law on February 15. The Federal legislation will require mammography facilities to include up-to-date information about breast density in mammography reports provided to patients and their physicians. This follows 36 state laws that require communication about breast density to women after their mammogram, according to DenseBreast-Info.org.
(#78) Surveillance imaging after MRI-guided breast biopsy varies by institution, radiologist (Health Imaging February 13, 2019) “Imaging follow-up protocols vary greatly by institution and radiologist after benign, concordant MRI-guided percutaneous core needle biopsies (MR-PCNB), according to research published online Feb. 7 in the Journal of the American College of Radiology.
Because no consensus guidelines for imaging follow-up protocols after benign concordant MR-PCNB exist, conflicting data and unclear management guidelines can lead to variability in radiology practices and uncertainty among breast radiologists and their patients, wrote lead author Bhavika K.
The study’s authors wrote that unnecessary biopsies and complications related to biopsies are often cited as potential harms of mammographic breast cancer screening, and the U.S. Preventive Services Task Force (USPSTF) specifically used such issues to help explain why it changed its mammography recommendations in 2009.
(#76) PET technique may allow for earlier measurement of breast cancer therapy effectiveness (Health Imaging February 11, 2019) “A molecular imaging technique using PET technology may improve how the efficacy or failure of hormone therapy is measured for breast cancer patients, according to research published online in the February issue of The Journal of Nuclear Medicine.
(#75) Mobile breast cancer screening unit to tour UAE (Radiology Business February 11, 2019) “A mobile breast cancer screening unit will soon tour the United Arab Emirates to offer free consultations, mammography screenings and genetic testing for men and women.
(#73) 14-layer CNN accurately predicts breast cancer molecular subtype (Health Imaging February 4, 2019) “A 14-layer convolutional neural network (CNN) trained on MRI and pathology data accurately predicted the molecular subtype of breast cancers, according to a Jan. 31 study published in the Journal of Digital Imaging.
(#72) New small cell lung cancer model reveals critical role of two mutated genes (Fierce BioTech February 11, 2019) “Small cell lung cancer (SCLC) develops mostly in smokers and is so aggressive it almost always becomes resistant to chemotherapy and radiation.
(#70) Are radiology reports too difficult for patients to understand? (Health Imaging January 18, 2019) “Although online portals allow some patients to easily access their radiology reports, a recent study published online Jan. 8 in the American Journal of Roentgenology found that lumbar spine MRI reports in particular are written at a reading level too advanced for the average patient to comprehend.
(#67) Providers need consensus guidelines for follow-up imaging after benign MRI-guided breast biopsies (Radiology Business February 8, 2019) “More consistent follow-up protocols after benign concordant MRI-guided percutaneous core needle biopsies (MR-PCNBs) could lead to better overall patient care, according to a case study published in the Journal of the American College of Radiology.
(#65) FDA updates providers on rare cancer associated with breast implants (Radiology Business February 7, 2019) “The FDA has published a new letter to providers in radiology, pathology, emergency medicine and several other specialties with updated information related to breast implant associated-anaplastic large cell lymphoma (BIA-ALCL).
(#64) Interacting with primary care physicians improves screening mammography adherence (Radiology Business February 7, 2019) “When primary care physicians (PCP) interact with their patients at a high level, it leads to improvements in breast cancer screening adherence for all racial and ethnic minority groups, according to new findings published in the Journal of the American College of Radiology.
(#60) Why health systems must embrace the forthcoming CDS mandate (Health Imaging January 29, 2019) “Upcoming legislation mandating the use of a clinical decision support (CDS) system when ordering advanced imaging tests could affect up to six million emergency department visits annually, according to estimates published in a Jan. 29 Radiology study.
(#59) Bundled payment model for breast cancer screening is realistic, study finds (Health Imaging January 23, 2019) “Previously established frameworks for creating breast cancer screening bundled payment models are achievable, according to a new study published in the Journal of the American College of Radiology.
In the study, researchers set out to evaluate the feasibility of a mammography bundled payment model and how a model for breast cancer screening created prior to widespread DBT adoption would fare after institutions have embraced the breast cancer screening method.”
(#58) OncoCyte blood test to rule out lung malignancies heads for commercial launch following study (Fierce Biotech January 29, 2019) “OncoCyte has delivered new positive results from a study of its DetermaVu blood test for lung cancer, which is designed to rule out patients who have a suspicious lung nodule but do not require an immediate biopsy.
(#56) DBT associated with lower recall rate, makes no impact on cancer detection rate (Radiology Business January 28, 2019) “The implementation of digital breast tomosynthesis (DBT) at eight radiology facilities in Vermont led to lower recall rates than full-field digital mammography (FFDM) alone, according to a new study published in the American Journal of Roentgenology.
(#55) Black women wait longer for breast surgery than white women, study finds (Health Imaging January 25, 2019) “New research involving breast cancer patients in the U.S. Military Health System found that black women wait longer to undergo breast cancer surgery after being diagnosed with the disease than white women, according to a study published Jan. 23 in JAMA Surgery.
(#53) How radiologists can eliminate these 4 lung cancer screening barriers (Health Imaging January 9, 2019) “A new article published in Radiology explores the barriers patients face in undergoing lung cancer screening (LCS), and more importantly, what radiologists can do to encourage their participation.
(NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the results of a long-term study conducted at Hoag Memorial Hospital Presbyterian with the Xoft® Axxent® Electronic Brachytherapy (eBx®) System® for the treatment of early-stage breast cancer using intraoperative radiation therapy (IORT).”
(#48) Preventing breast cancer metastasis by killing tumor cells in their sleep (Fierce Biotech January 21, 2019) “Oncology researchers have long believed that “dormant” breast cancer cells—those that have stopped dividing and are merely hiding out in the body—are unresponsive to chemotherapy.
(#47) Optical imaging system visualizes molecular features of breast cancer tissue in real-time (Health Imaging December 20, 2018 “A team of researchers from the University of Illinois at Urbana-Champaign has developed a portable optical imaging system that can visualize molecular features of breast tissue after it’s been surgically removed from a patient, according to research published online Dec. 19 in Science Advances.
(#46) Breast-specific gamma imaging could help predict pathologic response to chemotherapy (Health Imaging January 11, 2018) “Breast-specific gamma imaging (BSGI) performed with comparable sensitives in detecting residual tumor compared to breast MRI, and may be a more useful tool for predicting a complete pathologic response to neoadjuvant chemotherapy (NAC) in those with breast cancer, according to research published online Jan. 8 in the American Journal of Roentgenology.
(#44) Novel Technique May Significantly Reduce Breast Biopsies (Imaging Technology News January 17, 2019) “A novel technique that uses mammography to determine the biological tissue composition of a tumor could help reduce unnecessary breast biopsies, according to a new study appearing in the journal Radiology.1 Mammography has been effective at reducing deaths from breast cancer by detecting cancers in their earliest, most treatable stages.
(#42) Bundled payment model for breast cancer screening is realistic, study finds (Health Imaging January 23, 2019) “Previously established frameworks for creating breast cancer screening bundled payment models are achievable, according to a new study published in the Journal of the American College of Radiology.
In the study, researchers set out to evaluate the feasibility of a mammography bundled payment model and how a model for breast cancer screening created prior to widespread DBT adoption would fare after institutions have embraced the breast cancer screening method.”
(#41) DBT associated with more accurate biopsy recommendations (Radiology Business January 23, 2019) “Digital breast tomosynthesis (DBT) implementation in a diagnostic setting can result in an improved cancer detection rate (CDR) and more accurate biopsy recommendations, according to a new case study published in the Journal of the American College of Radiology.
“Studies in several radiology departments have cited various factors as important to patients including wait times, acknowledgment of concerns, friendliness of support staff, convenience of parking, and comfort of the waiting area,” wrote Neena Kapoor, MD, department of radiology at Brigham and Women’s Hospital in Boston, and colleagues.
(#39) Vancouver risk calculator found to improve lung cancer screening (Health Imaging January 22, 2019) “The Vancouver risk calculator (VRC) offers superior guidance in predicting the risk of malignancy in patients receiving CT lung cancer screening compared to the American College of Radiology Lung Imaging Reporting and Data System (Lung-RADS), according to a new study.
At Massachusetts General Hospital researchers have developed an AI algorithm to rapidly diagnose and classify brain hemorrhages from unenhanced computed tomography scans, detecting acute incidents and offering prediction capabilities that eventually could help staff in hospital emergency departments evaluate patients with acute stroke symptoms.”
Now, the world’s first genetic sequencing of precancerous lung lesions has allowed researchers for the first time, to discover the differences between the lesions that will become invasive and those that are harmless, and the subsequent development of a method that can accurately predict which lesions will become cancerous.
(#34) Breast MRI may help personalize treatment for DCIS patients (Health Imaging January 21, 2019) “Pairing breast MRI with a test that characterizes breast cancer genes can lead to a more personalized treatment approach for patients with ductal carcinoma in situ (DCIS), reported authors of a recent study published in JAMA Oncology.
(#33) DBT helps reduce recall rates, commit fewer patients to short-term follow-up (Radiology Business January 21, 2019) “Implementing digital breast tomosynthesis (DBT) can lead to fewer women being committed to short-term follow-up, according to new research published in Academic Radiology.
(#32) College of American Pathologists release digital pathology guidelines for testing breast cancer (Health Imaging January 18, 2019) “The College of American Pathologists released 11 new evidence-based clinical recommendations to help labs better use quantitative image analysis (QIA) in HER2 testing for breast cancer.
(#31) Plaque characteristics boost predictive power of CTA risk scoring (Cardiovascular Business January 18, 2019) “A CT angiography (CTA)-derived score that also incorporated the extent, location and composition of coronary plaque outperformed a model that focused only on the severity of stenosis, researchers reported Jan. 16 in JACC: Cardiovascular Imaging.
(#30) DBT outperforms FFDM when screening patients with dense breast tissue (Radiology Business January 18, 2019) “Invasive lobular, low-grade and HER-2-negative breast cancers are more detectable with digital breast tomosynthesis (DBT) than conventional full-field digital mammography (FFDM) when imaging patients with dense breasts, according to a new study published in the Korean Journal of Radiology.
(#29) Stationary DBT improves reader accuracy compared to mammography (Radiology Business January 17, 2019) “Stationary digital breast tomosynthesis (sDBT), which allows views to be collected without moving the x-ray tube, leads to improved reader accuracy compared to mammography, according to new findings published in Academic Radiology.
(#28) USPSTF recommends offering medication to women at increased risk for breast cancer (Radiology Business January 16, 2019) “The U.S. Preventive Services Task Force (USPSTF) has published a draft recommendation statement and draft evidence review that says clinicians should offer “risk-reducing medications” to women at an increased risk for breast cancer.
(#25) SBI publishes policy statement on diversity, inclusion (Radiology Business January 11, 2019) “The Society of Breast Imaging (SBI) has issued a new policy statement on diversity and inclusion, emphasizing the belief that “all people for whom breast cancer screening is appropriate should receive the opportunity to undergo screening.” The statement, produced by the SBI Communications and Advocacy Task Force, begins by noting that the most effective way to minimize the impact of breast cancer is for all women at an average risk to get annual screening mammograms beginning at the age of 40 and “continue as long as they are in good health.””
(#24) How a breast imaging center plans to improve patient-centered care (Health Imaging January 3, 2019) “Long wait times can negatively impact patient satisfaction, which then harms the patient-centered, value-based care imaging departments seek to provide.
At one large hospital-based outpatient breast imaging department, researchers implemented a real-time location system (RTLS) to pinpoint problems areas experienced when performing full field digital mammograms (FFDM) and digital breast tomosynthesis (DBT) exams.”
(#22) Researchers create less-invasive biosensor for breast cancer diagnosis (Verdict Medical Devices December 10, 2018) “A research team funded by the US National Institute of Biomedical Imaging and Bioengineering (NIBIB) has devised a new biosensor to diagnose breast cancer less invasively compared to the existing needle biopsy approach.
(#21) Myriad study shows breast cancer recurrence test can predict therapy responses (Fierce Biotech December 7, 2018) “Myriad Genetics presented new data on its EndoPredict test, saying it can accurately forecast which women with newly diagnosed ER-positive, HER2-negative breast cancer will see the most benefits from adjunctive chemotherapy.”
(#16) RSNA 2018: Cryoablation shows early effectiveness for low-risk breast cancer treatment (Health Imaging November 29, 2018) “Cryoablation—commonly called cryotherapy—demonstrated early effectiveness in treating women with low-risk breast cancer, reported researchers during a Nov. 29 session at RSNA’s 2018 Annual Meeting.
(#15) Predictive model may reduce overtreatment of ground glass nodules (Health Imaging November 20, 2018) “Ground glass nodule detection has risen alongside CT’s increased use in lung cancer screening, but pulmonary GGNs can represent various abnormalities, wrote Chen-Lu Liu, MD, with Nanjing Medical University’s Department of Radiology, and colleagues.
(#14) Computer uses machine learning to analyze breast cancer images (AI in Healthcare November 20, 2018) “With the help of machine learning, researchers were able to train a computer to analyze breast cancer images and classify tumors accurately, according to a study published in NPJ Breast Cancer.
(#13) Lung cancers efficiently identified, characterized with novel AI approach (Radiology Business November 20, 2018) “Researchers at the State University of New York at Stony Brook have demonstrated a deep-learning algorithm that can quickly diagnose early-stage lung cancer on CT scans by combining computerized self-trained tumor identification with engineered identification of specific tumor features such as texture…”
(#12) Husband-and-wife duo receives $1.8M to study new imaging technique for breast cancer patients (Radiology Business November 16, 2018) “The husband-and-wife duo led the development of a new technique called Precision Breast intraoperative radiation therapy (IORT), which reduces weeks of radiation treatments for patients by adding high-powered imaging to radiation therapy.
(#11) AI tool detects skin cancers better than dermatologists (AI in Healthcare November 16, 2018) “For the study, researchers trained and tested a deep-learning CNN on how well it could diagnosis skin lesions with melanoma or as benign nevi based on a test set of 100 images.
“The ACR DSI use cases present a pathway to help AI developers solve health care problems in a comprehensive way that turns concepts for AI solutions into safe and effective tools to help radiologists provide better care for our patients,” said Bibb Allen Jr., MD, ACR DSI Chief Medical Officer…”
Beijing Internet court launches AI judge
Beijing, Jun 27: The Beijing Internet court on Thursday launched an online litigation service centre including an AI judge which is claimed to be 'the first of its kind in the world'.The artificial intelligence judge will help the court's judges complete repetitive basic work, including litigation reception based on intelligent synthesising technologies of speech and image which will enable professional practitioners to focus on judicial trials, reported Xinhua.The judge has a female image with a voice, facial expressions and actions based on a real person.